Team Business Headline
Business Headline is a digital news media organisation which covers news related to Business and Stock Market and Technology related news.
Belo Sun Announces Reinstatement of Installation License for the Volta Grande Gold Project
TORONTO, Feb. 14, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX, OTCQB: BSXGF) is pleased to announce that the Federal Regional Court has accepted our appeal to reinstate the Installation License, which was suspended in 2017 for the Company’s Volta Grande Gold Project (the “Project”) located in Pará State, Brazil. Background As previously...
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Super One Planned to Enter the Pilot Build and Production Phase at...
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update
...
AVITA Medical to Host Investor Webinar Briefing
VALENCIA, Calif., Nov. 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company...
Ensurge Micropower ASA – Mandatory Notice of Trade for Primary Insiders
Reference is made to the stock exchange announcement from Ensurge Micropower ASA ("Ensurge" or the "Company") today regarding a private placement of shares in...
Ensurge Micropower ASA – Key information relating to possible repair issue/subsequent offering
Oslo, 9 November 2025 Reference is made to the stock exchange announcement from Ensurge Micropower ASA ("Ensurge" or the "Company") today regarding a...
Ensurge Micropower ASA – Private Placement successfully placed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE...
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data cutoff: 31 (97%)...
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions...
Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of lifeTHE WOODLANDS, Texas, Nov. ...
RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shift Away from Centralized Alternatives
DUBAI, United Arab Emirates, Nov. 08, 2025 (GLOBE NEWSWIRE) -- RZoasis, a next-generation Web3 infrastructure project, today announced the official launch of...
Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction in proteinuria, with a favorable safety profile ...
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular...
Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and cardiometabolic diseases, including pericarditis...
Ascot Announces Launch of C$0.01 Rights Offering
VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSXV: AOT.H; OTCQB: AOTVF) (“Ascot” or the “Company”) announces it...
South Star Announces Upsize of Non-Brokered Private Placement
- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE...